1. Home
  2. OGN vs CHX Comparison

OGN vs CHX Comparison

Compare OGN & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • CHX
  • Stock Information
  • Founded
  • OGN 1923
  • CHX 1882
  • Country
  • OGN United States
  • CHX United States
  • Employees
  • OGN N/A
  • CHX N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • CHX Industrial Machinery/Components
  • Sector
  • OGN Health Care
  • CHX Industrials
  • Exchange
  • OGN Nasdaq
  • CHX Nasdaq
  • Market Cap
  • OGN 4.7B
  • CHX 5.4B
  • IPO Year
  • OGN N/A
  • CHX N/A
  • Fundamental
  • Price
  • OGN $14.89
  • CHX $31.28
  • Analyst Decision
  • OGN Hold
  • CHX Buy
  • Analyst Count
  • OGN 3
  • CHX 4
  • Target Price
  • OGN $21.33
  • CHX $39.00
  • AVG Volume (30 Days)
  • OGN 3.2M
  • CHX 1.6M
  • Earning Date
  • OGN 10-31-2024
  • CHX 10-23-2024
  • Dividend Yield
  • OGN 7.51%
  • CHX 1.21%
  • EPS Growth
  • OGN 120.97
  • CHX 7.15
  • EPS
  • OGN 5.04
  • CHX 1.62
  • Revenue
  • OGN $6,409,000,000.00
  • CHX $3,665,501,000.00
  • Revenue This Year
  • OGN $3.13
  • CHX N/A
  • Revenue Next Year
  • OGN $2.18
  • CHX $3.90
  • P/E Ratio
  • OGN $2.95
  • CHX $19.30
  • Revenue Growth
  • OGN 4.21
  • CHX N/A
  • 52 Week Low
  • OGN $10.84
  • CHX $25.46
  • 52 Week High
  • OGN $23.10
  • CHX $39.95
  • Technical
  • Relative Strength Index (RSI)
  • OGN 29.13
  • CHX 57.37
  • Support Level
  • OGN $14.39
  • CHX $30.28
  • Resistance Level
  • OGN $15.85
  • CHX $32.08
  • Average True Range (ATR)
  • OGN 0.56
  • CHX 0.77
  • MACD
  • OGN -0.08
  • CHX 0.12
  • Stochastic Oscillator
  • OGN 13.76
  • CHX 79.75

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About CHX ChampionX Corporation

ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.

Share on Social Networks: